Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    3 0 0 0


Revue du rhumatisme
Volume 74, n° 7
pages 627-629 (juillet 2007)
Doi : 10.1016/j.rhum.2006.11.024
Received : 30 August 2006 ;  accepted : 6 November 2006
Myopathies inflammatoires et biothérapies
Biologics in the treatment of primary inflammatory myositis
 

Daniel Wendling
Service de rhumatologie, CHU Jean-Minjoz, 25030 Besançon, France 


Mots clés : Myosites, anti-TNF, Rituximab, Anakinra

Keywords : Myositis, TNF antagonists, Rituximab, Anakinra


  Pour cet article, utiliser ce titre en anglais et sa référence dans le même volume de Joint Bone Spine .


© 2007  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline